Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Canaccord Genuity Starts Entellus Medical (ENTL) at Buy
-
Sovaldi Pricing Controversy Offers Little Read-Through for PSCK9s - Canaccord (REGN) (GILD) (AMGN)
-
Notable Analyst Rating Changes 2/20: (MRVL) (DSW) (KN) Upgraded; (FUEL) (HLSS) (REGN) Downgraded
-
UPDATE: Canaccord Genuity Downgrades Northern Oil and Gas (NOG) to Hold
-
UPDATE: Canaccord Genuity Downgrades Approach Resources (AREX) to Hold
-
UPDATE: Canaccord Genuity Upgrades DSW Inc. (DSW) to Buy
-
Novatel Wireless (MIFI) PT Lifted to $5 at Canaccord Genuity
-
Astronics (ATRO) PT Raised to $77 at Canaccord Genuity
-
Integra LifeSciences to Participate in the Raymond James Institutional Investors Conference, Barclays Global Healthcare Conference and the Canaccord Genuity Musculoskeletal Conference in March
-
Some FY15 Targets for Stratasys (SSYS) Appear Conservative; Canaccord Affirms at 'Buy'
-
UPDATE: Canaccord Genuity Downgrades Castlight Health Inc. (CSLT) to Hold
-
UPDATE: Canaccord Genuity Upgrades Hologic (HOLX) to Buy; Survey 'Overwhelmingly Positive'
-
SolarCity (SCTY) PT Raised to $67 at Canaccord Genuity
-
Actavis (ACT) PT Lifted to $352 at Canaccord Genuity
-
Inotek Pharma (ITEK) IPO Opens Modestly Higher
-
UPDATE: Canaccord Genuity Starts Celgene (CELG) at Buy
-
UPDATE: Canaccord Genuity Downgrades Insulet Corporation (PODD) to Hold
-
Inotek Pharma (ITEK) Prices 6.67M Common IPO at $6/Share; Announces $20M Conv. Senior Notes Offering
-
Notable Analyst Rating Changes 2/17: (SRPT) (MU) (CCG) Upgraded; (IMAX) (CVC) (JWN) Downgraded
-
UPDATE: Canaccord Genuity Downgrades IMAX Corporation (IMAX) to Hold
-
Ultragenyx Announces Full Exercise of Underwriters' Option to Purchase Additional Shares
-
Canaccord Genuity Starts Box, Inc. (BOX) at Hold
-
Stryker (SYK) Can Get a Smith & Nephew (SNN) Deal Done at $45/Share - Canaccord Genuity
-
Cognex (CGNX) PT Lifted to $55 at Canaccord Genuity on 'Solid' Q4
-
Zynga (ZNGA) PT Cut to $2.50 at Canaccord Genuity
-
ReWalk Robotics (RWLK) PT Cut at $17 at Canaccord Genuity
-
RTI Biologics (RTIX) PT Lifted to $7 at Canaccord Genuity
-
Digital Realty Trust (DLR) PT Bumped to $72 at Canaccord Genuity
-
Klox Technologies (KLOX) Files for $75M IPO
-
Notable Analyst Rating Changes 2/12: (ALLY) (CPA) (MOS) Upgraded; (TSLA) (FTI) (ZU) Downgraded
-
Transition Therapeutics (TTHI) Prices 3.08M Share Offering at $6.50/Sh
-
Canaccord Genuity Downgrades Zulily, Inc (ZU) to Hold
-
Transition Therapeutics (TTHI) to Offer Common Stock
-
Akamai (AKAM) PT Raised to $75 at Canaccord Genuity Amid Strong Q4; Sees 'Beat-and-Raise' Type Year Ahead
-
Notable Analyst Rating Changes 2/10: (STJ) (C) (TE) Upgraded; (RIG) (BPZ) (GPS) Downgraded
-
Canaccord Genuity Upgrades Tahoe Resources (TAHO) to Buy
-
Canaccord Genuity Starts Pernix Therapeutics (PTX) at Buy
-
Using History as a Guide, Weakness in American Tower (AMT) is a Buying Opportunity - Canaccord Genuity
-
Apple (AAPL) Price Target Lifted to $145 at Canaccord Genuity
-
Notable 52-Week Highs and Lows 2/6: (NXPI) (FTR) (LNKD) High; (P) (NOV) (MXWL) Low
-
NXP Semiconductors (NXPI) PT Raised to $97 at Canaccord Genuity
-
Ultragenyx Pharmaceutical (RARE) 3M Offering Prices at $54/Share
-
Notable Analyst Rating Changes 2/4: (SFUN) (SYK) (EXPR) Upgraded; (GDP) (GTE) (BBEP) Downgraded
-
Pre-Open Stock Movers 02/04: (NES) (ENTR) (SJM) Higher; (RL) (GLID) (SPLS) Lower (more...)
-
Spirit AeroSystems (SPR) PT Raised to $60 at Canaccord Genuity
-
Continental Resources (CLR) PT Raised to $54 at Canaccord Genuity
-
Canaccord Genuity Downgrades Goodrich Petroleum (GDP) to Hold
-
Ultragenyx Pharmaceutical (RARE) to Offer $125M in Common Stock
-
Canaccord Genuity Sees Solid Q4 Report for Under Armour (UA)
-
UPDATE: Canaccord Genuity Downgrades Michael Kors (KORS) to Hold

